07.12.2012 Views

Evaluating the “Good Death” Concept from Iranian Bereaved Family

Evaluating the “Good Death” Concept from Iranian Bereaved Family

Evaluating the “Good Death” Concept from Iranian Bereaved Family

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Mission<br />

The mission of The Journal of Supportive<br />

Oncology is <strong>the</strong> publication<br />

of articles and original research<br />

relating to practical management<br />

issues in <strong>the</strong> palliative and<br />

supportive care of patients with<br />

neoplastic diseases. The articles<br />

aim to be of broad relevance to<br />

<strong>the</strong> clinical problems faced by <strong>the</strong><br />

practicing oncologist, bringing<br />

research findings <strong>from</strong> bench to<br />

bedside. The journal focuses on<br />

<strong>the</strong> integration of supportive and<br />

palliative oncology into <strong>the</strong> care<br />

of all oncology patients, <strong>from</strong><br />

diagnosis to cure and beyond<br />

or death.<br />

Disclaimer<br />

Discussions, views, opinions, and<br />

recommendations as to medical<br />

procedures, products, choice of<br />

drugs, and drug dosages are <strong>the</strong><br />

responsibility of <strong>the</strong> authors or<br />

advertisers. No responsibility is<br />

assumed by <strong>the</strong> Publisher, Editor,<br />

or Editorial Board for any injury<br />

and/or damage to persons or<br />

property as a matter of products<br />

liability, negligence or o<strong>the</strong>rwise,<br />

or <strong>from</strong> any use or operation of any<br />

methods, products, instructions,<br />

or ideas contained in <strong>the</strong> material<br />

herein. Because of rapid advances<br />

in <strong>the</strong> medical sciences, independent<br />

verification of diagnoses and<br />

drug dosages should be made.<br />

Advertise and advertising agency<br />

recognize and accept that <strong>the</strong> following<br />

language appears within<br />

<strong>the</strong> publication: ‘‘All statements, including<br />

product claims, are those<br />

of <strong>the</strong> person or organization making<br />

<strong>the</strong> statement or claim. The<br />

Publisher does not adopt any such<br />

statement or claim as its own, and<br />

any such statement or claim does<br />

not necessarily reflect <strong>the</strong> opinion<br />

of <strong>the</strong> Publisher.’’ Advertiser and<br />

advertising agency accept and<br />

assume liability for all content<br />

(including text, representations,<br />

illustrations, opinions, and facts)<br />

of advertisements printed and<br />

also assume responsibility for any<br />

claims made against <strong>the</strong> Publisher<br />

arising <strong>from</strong> or related to such<br />

advertisements.<br />

In <strong>the</strong> event that legal action or<br />

a claim is made against <strong>the</strong> Publisher<br />

arising <strong>from</strong> or related to<br />

such advertisements, advertiser<br />

and advertising agency agree to<br />

fully defend, indemnify, and hold<br />

harmless <strong>the</strong> Publisher and to pay<br />

any judgment, expenses, and legal<br />

fees incurred by <strong>the</strong> Publisher as a<br />

result of said legal action or claim.<br />

The Publisher reserves <strong>the</strong> right to<br />

reject any advertising that he feels<br />

is not in keeping with <strong>the</strong> publication’s<br />

standards.<br />

The Publisher is not liable for<br />

delays in delivery and/or nondelivery<br />

in <strong>the</strong> event of Act of<br />

God, action by any government<br />

or quasi-governmental entity, fire,<br />

flood, insurrection, riot, explosion,<br />

embargo, strikes (whe<strong>the</strong>r legal or<br />

illegal), labor or material shortage,<br />

transportation interruption of any<br />

kind, work slow-down, or any condition<br />

beyond <strong>the</strong> control of <strong>the</strong><br />

Publisher that affects production<br />

or delivery in any manner.<br />

This journal is printed on paper<br />

meeting <strong>the</strong> requirements of<br />

ANSI/NISO Z39.48-1992 (Permanence<br />

of Paper) effective with<br />

Volume 1, Issue 1, 2003.<br />

ORIGINAL RESEARCH<br />

59 <strong>Evaluating</strong> <strong>the</strong> <strong>“Good</strong> <strong>Death”</strong> <strong>Concept</strong> <strong>from</strong> <strong>Iranian</strong> <strong>Bereaved</strong> <strong>Family</strong><br />

Members’ Perspective<br />

Sedigheh Iranmanesh, PhD, Habibollah Hosseini, doctoral student, and<br />

Mohammad Esmaili, MSc student, Razi Faculty of Nursing and Midwifery, Kerman Medical University,<br />

Kerman, Iran.<br />

64 Symptom Experience in Patients with Gynecological Cancers: The<br />

Development of Symptom Clusters through Patient Narratives<br />

Violeta Lopez, RN, PhD, Gina Copp, RN, PhD, Lisa Brunton, RN, MSN, and<br />

Alexander Molassiotis, RN, PhD, Research Centre for Nursing and Midwifery Practice, Australian National<br />

University, Medical School, Canberra, Australia; School of Health and Social Sciences, Middlesex University,<br />

London; School of Nursing, Midwifery and Social Work, University of Manchester, Manchester, United<br />

Kingdom.<br />

72 Estimating Minimally Important Differences for <strong>the</strong> Worst Pain<br />

Rating of <strong>the</strong> Brief Pain Inventory–Short Form<br />

Susan D. Mathias, MPH, Ross D. Crosby, PhD, Yi Qian, PhD, Qi Jiang, PhD, Roger Dansey, MD, and<br />

Karen Chung, PharmD, MS, From Health Outcomes Solutions, Winter Park, Florida; Biomedical Statistics and<br />

Methodology, Neuropsychiatric Research Institute, Fargo, North Dakota; Global Biostatistics, Global<br />

Development, and Global Health Economics, Amgen, Inc., Thousand Oaks, California.<br />

79 A Pilot Trial of Decision Aids to Give Truthful Prognostic and<br />

Treatment Information to Chemo<strong>the</strong>rapy Patients with Advanced<br />

Cancer<br />

Thomas J. Smith, MD, Lindsay A. Dow, MD, Enid A. Virago, MDiv, James Khatcheressian, MD,<br />

Robin Matsuyama, PhD, and Laurel J. Lyckholm, MD, Massey Cancer Center of Virginia Commonwealth<br />

University, School of Education, VCU School of Medicine, Department of Social and Behavioral Health, and <strong>the</strong><br />

Virginia Cancer Institute, Richmond, Virginia.<br />

Available on www.SupportiveOncology.net<br />

GUIDE FOR AUTHORS<br />

Our Guide for Authors and submission process has changed.<br />

Please visit our website www.SupportiveOncology.net and click on Guide for Authors<br />

for fur<strong>the</strong>r information.<br />

VOLUME 9, NUMBER 2 � MARCH/APRIL 2011 www.SupportiveOncology.net iii

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!